SARS-CoV Spike anticorps

N° du produit ABIN2452119

Cet anticorps anti-SARS-CoV Spike est un anticorps Souris Monoclonal détectant SARS-CoV Spike dans ELISA, WB, IF et IC. Adapté pour SARS Coronavirus (SARS-CoV). Ce Primary Antibody a été cité dans 5+ publications.

Aperçu rapide pour SARS-CoV Spike anticorps (ABIN2452119)

Antigène: SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

Reactivité: SARS Coronavirus (SARS-CoV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SARS-CoV Spike est non-conjugé

Application: ELISA, Western Blotting (WB), Immunofluorescence (IF), Immunochromatography (IC)

Clone: 3A2

Détail du produit anti-SARS-CoV Spike anticorps

Attributs du produit: Monoclonal antibody 3A2 recognizes the spike protein consisting of 1181 amino acids, which migrates at 200 kDa position on SDS-PAGE due to its glyco-chains.

Purification: Purified

Stérilité: Sterile filtered

Isotype: IgG2b kappa

Information d'application

Indications d'application: 1) Western blotting: 0. 1~0. 3 g/mL
2) Immunofluoresece staining (IHC)
3) ELISA Isoform: IgG2b (kappa)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol

Agent conservateur: Azide free

Stock: -20 °C/-80 °C

Stockage commentaire: -20 C (For long term storage: -80 C)

Références pour anticorps anti-SARS-CoV Spike (ABIN2452119)

Jin, Nesbitt, Yang, Chen, Horowitz, Jones, Vandergaast, Carey, Reiter, Russell, Kyratsous, Hooper, Hamilton, Ferreira, Deng, Straus, Baras, Hillyer, Luchsinger: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." dans: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).

Nesbitt, Jin, Hogan, Yang, Chen, Chan, Simon, Vargas, King, Huard, Bandy, Hillyer, Luchsinger: "Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats." dans: BMC infectious diseases, Vol. 21, Issue 1, pp. 871, (2021) (PubMed).

Luchsinger, Ransegnola, Jin, Muecksch, Weisblum, Bao, George, Rodriguez, Tricoche, Schmidt, Gao, Jawahar, Pal, Schnall, Zhang, Strauss, Yazdanbakhsh, Hillyer, Bieniasz, Hatziioannou: "Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients." dans: Journal of clinical microbiology, (2020) (PubMed).

Satija, Lal: "The molecular biology of SARS coronavirus." dans: Annals of the New York Academy of Sciences, Vol. 1102, pp. 26-38, (2007) (PubMed).

Yamate, Yamashita, Goto, Tsuji, Li, Warachit, Yunoki, Ikuta: "Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus." dans: Microbes and infection / Institut Pasteur, Vol. 7, Issue 15, pp. 1530-40, (2005) (PubMed).

Détails sur SARS-CoV Spike

Antigène: SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))

Autre désignation: SARS-CoV Spike

Classe de substances: Viral Protein

Sujet: A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and directly binds to the virus receptor, ACE2 (Angiotensin-Converting Enzyme 2). Hybridoma 3A2 has been isolated by injecting mouse with SARS virus and as the clone which produces antibody that specifically reacts with the virus-infected cell, in the laboratory of Prof. K. Ikuta of Osaka University.